IL22RA2 and tuberculosis: A net score combining IP-10, IL-22BP, and sCD163 (although the cut-off points were selected statistically without definite priori biological reasoning), developed in our study, appears to help predict the inflammation perturbation caused by TB medications which predispose TB patients to DILI development.